Document is current
Any future updates will be listed below
-
Authors
Hillmer, A T
Sandiego, C M
Hannestad, J
Angarita, G A
Kumar, A
McGovern, E M
Huang, Y
O'Connor, K C
Carson, R E
O'Malley, S S
Cosgrove, K P
- License Information
-
More Information
Article History
Received: 30 September 2016
Revised: 14 November 2016
Accepted: 19 December 2016
First Online: 28 February 2017
Competing interests
: JH was a full-time employee of UCB Pharma at the time this study was planned and conducted. KCO’C was speaking honoraria at Genentech, EMD Serono and a consultant at NeuroPhage Pharmaceuticals, Scitemex. Although not directly relevant to the reported work, SSO’M reports the following: donated study medications from AstraZeneca, Pfizer; consultant or advisory board member at Alkermes, Cerecor, Opiant; Scientific Review Group, Hazelden Betty Ford Foundation; member of the American Society of Clinical Pharmacology Alcohol Clinical Trials Initiative supported by Ethypharm, Lilly, Lundbeck, Otsuka, Pfizer, Arbor Pharmaceuticals, Indivior. The remaining authors declare no conflicts of interest.
